文献速递耳科与耳神经

MicroRNA 谱分析作为梅尼埃病诊断方法:机器学习潜在应用

MicroRNA Profiling as a Methodology to Diagnose Ménière's Disease: Potential Application of Machine Learning.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-07-14

本研究通过迷宫切除术(梅尼埃病,n=5)、镫骨切开术(耳硬化症,n=5)和人工耳蜗植入(感音神经性听力损失,n=9)采集外淋巴液,分析 miRNA 表达谱,并采用机器学习分类模型(80/20 训练/测试拆分与交叉验证)评估其预测梅尼埃病诊断的能力。结果显示,机器学习模型能以外淋巴 miRNA 谱 100% 准确区分传导性听力损失与梅尼埃病,但区分感音神经性听力损失与梅尼埃病的最佳模型准确率仅 66%。

要点

  • 外淋巴 miRNA 谱分析可作为安全的液体活检方法用于梅尼埃病诊断。
  • 机器学习模型能 100% 准确区分传导性听力损失与梅尼埃病。
  • 机器学习模型区分感音神经性听力损失与梅尼埃病的准确率较低(最佳 66%)。

核心结论

  • 机器学习可仅基于 miRNA 谱构建梅尼埃病特异性预测模型,但区分感音神经性听力损失与梅尼埃病的准确率较低。

研究设计与样本

  • 前瞻性队列研究,在三级学术医院进行,收集迷宫切除术(梅尼埃病,n=5)、镫骨切开术(耳硬化症,n=5)和人工耳蜗植入(感音神经性听力损失,n=9)的外淋巴液。

主要发现

  • 对于传导性听力损失与梅尼埃病的 miRNA 谱,4 个模型能以 100% 准确率区分并识别两种疾病类别。
  • 表现最佳的模型在决策分类模型中使用相同的 miRNA,但权重值不同。
  • 所有区分感音神经性听力损失与梅尼埃病的候选模型表现显著较差,最佳模型准确率为 66%。
  • 梅尼埃病模型显示出与感音神经性听力损失不同的独特特征。

临床怎么用

  • 外淋巴 miRNA 谱分析结合机器学习可能成为梅尼埃病的诊断工具,但需进一步验证。

局限性

  • 样本量较小(梅尼埃病 n=5,耳硬化症 n=5,感音神经性听力损失 n=9)。
  • 机器学习模型区分感音神经性听力损失与梅尼埃病的准确率较低,可能因 miRNA 生物标志物重叠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diagnosis and treatment of Ménière's disease remains a significant challenge because of our inability to understand what is occurring on a molecular level. MicroRNA (miRNA) perilymph profiling is a safe methodology and may serve as a "liquid biopsy" equivalent. We used machine learning (ML) to evaluate miRNA expression profiles of various inner ear pathologies to predict diagnosis of Ménière's disease. STUDY DESIGN: Prospective cohort study. SETTING: Tertiary academic hospital. SUBJECTS AND METHODS: Perilymph was collected during labyrinthectomy (Ménière's disease, n = 5), stapedotomy (otosclerosis, n = 5), and cochlear implantation (sensorineural hearing loss [SNHL], n = 9). miRNA was isolated and analyzed with the Affymetrix miRNA 4.0 array. Various ML classification models were evaluated with an 80/20 train/test split and cross-validation. Permutation feature importance was performed to understand miRNAs that were critical to the classification models. RESULTS: In terms of miRNA profiles for conductive hearing loss versus Ménière's, 4 models were able to differentiate and identify the 2 disease classes with 100% accuracy. The top-performing models used the same miRNAs in their decision classification model but with different weighted values. All candidate models for SNHL versus Ménière's performed significantly worse, with the best models achieving 66% accuracy. Ménière's models showed unique features distinct from SNHL. CONCLUSIONS: We can use ML to build Ménière's-specific prediction models using miRNA profile alone. However, ML models were less accurate in predicting SNHL from Ménière's, likely from overlap of miRNA biomarkers. The power of this technique is that it identifies biomarkers without knowledge of the pathophysiology, potentially leading to identification of novel biomarkers and diagnostic tests.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Shew M, Wichova H, Bur A, et al. MicroRNA Profiling as a Methodology to Diagnose Ménière's Disease: Potential Application of Machine Learning. Otolaryngol Head Neck Surg. 2020. PMID: 32663060. doi:10.1177/0194599820940649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。